测量远端气道炎症可改善哮喘急性发作预测
该前瞻性研究纳入68名哮喘儿童(共134次访视),评估呼出气一氧化氮分区参数与后续哮喘急性发作的关联。结果显示仅肺泡一氧化氮浓度(CalvNO)在发作组与无发作组间有差异(p<0.001),CalvNO>7 ppb预测发作特异性90.9%,阳性似然比3.1;CalvNO<4 ppb排除发作敏感性71.4%,阴性似然比0.48;两次访视间CalvNO升高0.5 ppb预测发作敏感性92%、特异性92%、阳性似然比11.8、阴性似然比0.08。结论提示评估CalvNO可改善对后续发作的预测。
要点
- CalvNO>7 ppb预测哮喘发作特异性90.9%,阳性似然比3.1。
- CalvNO<4 ppb排除发作敏感性71.4%,阴性似然比0.48。
- 两次访视间CalvNO升高0.5 ppb预测发作敏感性92%、特异性92%。
核心结论
- 评估CalvNO可改善对后续哮喘急性发作的预测,凸显远端气道炎症在儿童哮喘结局中的重要性。
研究设计与样本
- 前瞻性研究纳入68名哮喘儿童(平均±标准差年龄9.0±2.4岁),共134次访视,记录急性发作。
主要发现
- 99次访视无发作(组1),35次访视记录到发作(组2)。
- 组1与组2的FENO50中位数(范围)分别为12.7(4–209)ppb与13.5(3.8–149.9)ppb,无差异。
- 组1与组2的CalvNO中位数(范围)分别为3.4(0.2–10.8)ppb与5.2(1.7–23.6)ppb,差异有统计学意义(p<0.001)。
- JawNO、DawNO、CawNO在两组间无差异。
关键数值与推荐
- CalvNO>7 ppb预测哮喘发作特异性90.9%,阳性似然比3.1。
- CalvNO<4 ppb排除发作敏感性71.4%,阴性似然比0.48。
- 两次访视间CalvNO升高0.5 ppb预测发作敏感性92%、特异性92%、阳性似然比11.8、阴性似然比0.08。
临床怎么用
- 在儿童哮喘随访中可考虑检测CalvNO以辅助预测后续急性发作风险。
- CalvNO>7 ppb提示发作风险升高,CalvNO<4 ppb有助于排除发作。
- 关注两次访视间CalvNO升高0.5 ppb的动态变化以识别发作风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Partitioning parameters measured from exhaled nitric oxide, such as the alveolar concentration of nitric oxide (CalvNO), may provide better predictors of future asthma exacerbation than exhaled nitric oxide fraction at an expiratory flow rate of 50 mL·s−1 (FENO50). We aimed to determine whether any partitioned nitric oxide parameters were more closely associated than FENO50 with subsequent asthma exacerbations. METHODS: 68 asthmatic children (mean±sd age 9.0±2.4 years) were followed prospectively (134 visits) and exacerbations were recorded. Childhood Asthma Control Test (cACT), spirometry, FENO50, CalvNO, bronchial flux of nitric oxide (JawNO), transfer factor of nitric oxide (DawNO) and airway wall concentration of nitric oxide (CawNO) were measured. RESULTS: No exacerbation was recorded in 99 visits (Group 1) and an exacerbation was recorded in 35 visits (Group 2). The median (range) FENO50, JawNO, CalvNO, DawNO and CawNO of Group 1 versus Group 2: 12.7 (4–209) versus 13.5 (3.8–149.9) ppb, 715 (10–12 799) versus 438 (40–7457) pL·s−1, 3.4 (0.2–10.8) versus 5.2 (1.7–23.6) ppb, 38.3 (0.2–113.3) versus 38 (1.3–144.5) pL·s−1·ppb−1 and 26.8 (4.1–2163) versus 29.9 (5.5–3054) ppb, respectively. Other than for CalvNO (p<0.001), there was no difference between the two groups. CalvNO >7 ppb predicted asthma exacerbation with specificity 90.9% and positive likelihood ratio (LR) 3.1. Conversely, CalvNO <4 ppb excluded an exacerbation with sensitivity 71.4% and negative LR 0.48. An increase of CalvNO by 0.5 ppb between visits could also predict an exacerbation with sensitivity 92%, specificity 92%, positive LR 11.8 and negative LR 0.08. CONCLUSIONS: Assessment of CalvNO improved prediction of subsequent exacerbation, highlighting the importance of distal inflammation in asthma outcomes in children.
引用
- Paraskakis, Sarikloglou, Fouzas, et al. Improved prediction of asthma exacerbations by measuring distal airway inflammation. Eur Respir J. 2022. PMID: 35086836. doi:10.1183/13993003.01684-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。